Sunshine Biopharma Inks $4M At-The-Market Sales Agreement With Aegis Capital
https://www.sec.gov/ix?doc=/Archives/edgar/data/1402328/000168316826005656/sunshine_8k.htm
Share
Why It Matters
Sunshine Biopharma made a deal to sell up to $4 million of its own stock whenever it wants to raise money. This is a tool companies use to fund their work, so watch if they actually use it—that tells you if they need cash soon.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.